Headline

Analysis Type: Analysis of Covariance (ANCOVA) with Type III sum of squares
Covariates Controlled: Baseline severity and age
Outcome: Primary continuous endpoint compared across treatment groups

None of the three treatment groups showed a meaningful difference in outcomes after adjusting for age and blood pressure (F=0.27, p=0.765).

Purpose

This ANCOVA section tests whether Drug A, Drug B, and Placebo produce different results on the primary outcome, while statistically removing the influence of two patient characteristics (age and diastolic blood pressure) that could confound the comparison. This is the core hypothesis test for the trial—it answers whether the treatments actually work differently from each other.

Key Findings

F-statistic: 0.27 with p-value of 0.765 — far above the 0.05 significance threshold, indicating no detectable treatment effect
Partial eta-squared: 0.000 — the treatment groups explain zero percent of outcome variance after covariate adjustment
Model R-squared: 0.002 — even with covariates included, the entire model explains only 0.2% of outcome variation
Sample size: 1,000 patients across three groups provides strong statistical power to detect real differences, yet none emerged

Interpretation

The analysis found no evidence that Drug A, Drug B, or Placebo differ meaningfully in their effect on the outcome. The p-value of 0.765 means there is a 76.5% probability of observing this data (or more extreme) if all three treatments truly had identical effects. The negligible effect size confirms this is not a case of a real but small difference being missed due to sample size—the groups genuinely performed similarly. Adjusting for age and baseline blood pressure did not reveal hidden treatment effects.

Context

With 1,000 patients, the study had excellent power to detect even modest treatment differences. The failure to find significance is not due to insufficient sample size. However, the extremely low model R² (0.2%) suggests substantial unexplained outcome variation, indicating either high individual variability in response or unmeasured confounding factors.